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SS showed no systematicchangesoverthesame experimentalperiod. We
conclude: (1) Proportional reductions in myocardial metabolism and function
develop following repeated brief coronary occlusions (a mild preconditioning
stimulus in dogs); (2) These findings indicate that a transiently downregu-
Iated energy demand may indeed be one of the factors influencing classic
preconditioning.
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of myocardial infarct aiza by partial raduction of
blood aupply combinad with pacing of tha
gaatrocnamiua muacle
Y. Birnbaum, R.A. Kloner. Good Samaritan Hospital, University of Southern
Cdifomia, Los Angeles, CA, USA
Ischemic preconditioning, the limitation of infarct size by preceding brief
complete occlusion of the infarct related mronaty artery, is well described.
However,whether pacing-induced ischemiaof skeletal muscle can precondi-
tion the myocardium is unknown. We assessed the effect of preconditioning
at a distance, induced by partial reduction of blood flow to a hind limb
combined with muscle pacing, on myocsrdial infarct-size (IS). Anesthetized
rabbits were randomized to 30 min of: waiting period (controls); 60-70%
reduction of femoral artery blood flow (stenosis); gastrocnemiua muscle pac-
ing at a rate of I/second (pacing); or 60-70% reduction of femoral artery
flow and gastrocnemius pacing (stenosis+ pacing). Thereafter, rabbits were
subjected to 30 min of coronary attery occlusion and 4 h of reperfusion. Each
group included 8 rabbits. Risk-zone (RZ) was assessed by blue dye and
infarct-aize by tetrazolium ataining. The size of RZ was comparable among
groups. However, the ratio of IS/RZ was smaller in the stenosis + pacing
group (0.09 + 0.02), as compared with the control (0.26 + 0.03), stenosis
(0.36 + 0.05), and pacing (0.30 + 0.05) groups (p = 0.0006). Analysis of
covariance testing for group effect performed on the volume of IS and the
volume of RZ revealed a significant group effect (p = 0.0004). Peripheral
muscle stimulation combined with restriction of bleed flow, preconditioned
the myocardium. These results suggest that oxygen supply-demand imbal-
ance of a remote organ can ischemioally precondition the myocerdium at a
distance, supporting a potential humoral mechanism.
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lachemia and prevanta left ventricular dysfunction
during PTCA. Clinical access to ischemic
preconditioning?
U.E. Heidland, M.P. Heintzen, B. Schwattzkopff, B.E. Strauer.
Heinrich-Heine-University Dusseldorf, Germany
Ischemic preconditioning has been shown to protect the myocardium from a
subsequent ischemic insult. Adenosine represents an important mediator of
iachemic preconditioning. PTCA is a suitable tool to study the response of the
human myocerdium to subsequent periods of ischemia. The purpose of this
study is to evaluate, if intrecoronaty pretreatment with the adenoaine-agonist
dipyrfdamole (dip) reduces PTCA-induced ischemic complications. 46 pa-
tients (41 men, 5 women, age = 64.1 + 2.3 a) were randomised to receive
ekher conventional pretreatment or dip pretreatment (0.5 mg/kg bodyweight)
prior to PTCA for stable ischemia. Patients receiving dip tolerated longer
balloon inflation times (155.3 + 14.4s vs. 93.1 + 5.2s; p < 0.001), accom-
panied by a reduction in ST-segment elevation (0.27 + 0.01 mV va. 0.16 +
0.02 mV; p < 0.01) and a reduction in anginal pain. In 20 patients (18 men,
2 women, age = 62.6 + 2.9a) receiving randomization concerning conven-
tional pretreatment or dip, registration of hemodynamice and left ventricular
angiography were performed before and at the end of PTCA. Patients receiv-
ing conventional pretreatment exhibited a dramatic decline in left ventricular
ejection fraction during PTCA (77.2 + 2.3Y0before PTCA vs. 54.6 + 3.1%
during PTCA, p c 0.031), while dip pretreatment prevented a significant
reduction (66.0 * 4.0% before PTCA vs. 66.1 + 3.7% during PTCA, n.s.).
It ia mncluded, that intracoronaty dip increaaes tolerance to ischemia and
prevents myocardial dysfunction during PTCA. One possible explanation is
induction of iachemic preconditioning.
9:15
776-4 Blockade of nitric oxide improve myocardial
metabolism during iechemia independent of
preconditioning effect
M. Araki, M. Tanaka, K. Hasegawa, S. Sasayama. Kyoto University Kyoto,
Jspsn
The expression of nitric oxide aynthase (NOS) can be induc&l by various
kinds of stimuli including hypoxia. Since NO has multiple biological actiona,
it may play a cerdio-toxic or -protective role in the process of myocerdial
ischemia (1)and reperfusion (R). A relatively large dose of NOS inhibitor re-
duces regional myocsrdial blood flow (RMBF) and is cardioprotective againat
subsequent ischemia by preconditioning effect. However, a role of endoge-
nous NO in I and R independent of preconditioning effect haa not been
clarified. We studied the effect of a low dose of L-nitro-arginine methyl ester
(L-NAME), a NOS inhibitor on myocardial metabolism during I and R in vivo.
In an open-chest pig model, we measured tisaue levels of ATP and pH in
the area at risk by 3’ P-nuclear magnetic reaonance spectroempy. A bolus
injection of 0.74 mol/kg of L-NAME (n = 8) into the right atria did not alter
tissue metabolism or RMBF (0.76 + 0.11 to 0.76 + 0.13, NS) meaaured by
colorsd microsphere compared with.placebo saline (n = 9). These indicate
this dosage of L-NAME did not elicit ischemic preconditioning. During sub-
sequent 15-min regional I by coronary ligation, tissue levels of pH and ATP
were significantly presemd in the L-NAME group compared with the placebo
group (pH: 6,67 + 0.06 vs 6.30 + 0.08, p <0.05 and % ATP: 74.9 + 7.5 vs
51.8 + 4.0, p < 0.05). However, the metabolism did not differ between the
L-NAME and placebo groups during subsequent 120-min R. Double products
were similar between these two groups throughout experiments. Thus, block-
ade of NO was cardioprotective in I independent of preconditioning effect,
suggesting a cytotoxic role of endogenous NO in myocardiai metabolism
during 1.
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Continuous administration of aminoguanldine
inhibits inducibla nitric oxide synthaae and exerts
protective affacts in a rabbit model of iachemia and
reperfusion
S.M. Wildhirtl, H. Suzuki2, D. Horstman 2, W.-P.Wolf 1, C. Schulze 1,
M. Weis’, B. Reichart 1.1 Depts. of Cardiac Surgery University ofhfurrich,
GermanK 2Huntington Medical Research Inatitute, Pasadena, CA, USA
In cardiac disorders including acute myocardial infarction or acute allograft
rejection the inducible nitric oxide synthase (iNOS) activity is significantly
increased. We investigated the effects of continuous inhibition of inducible
nitric oxide synthase (iNOS) by aminoguanidine (AG) in a model of 30 min.
of ischemia followed by 48 h of reperfusion. Eighteen male New Zealand
White rabbits were subjected to ligation of the circumflex coronary artery.
Animals were randomly assigned to the following groups: A) Sham (n =6); B)
Ischemidreperfusion + Placebo (l/R) (n =6); l/R +AG (300 mg/kg/day/sc; n =
6), Left ventricular systolic (LVSP)and diastolic pressure (LVEDP), maximum
+dP/dt and -dP/dt were monitored. Infarct aize was determined by triphenyl-
tetrazolium staining. Inducible NOS (fmol/Mg) was assayed by conversion
of L-14C-arginine to L-14C-citrulline. Tissue levels of AG were measured
by spectrophotometry. Aminoguanidine significantly inhibited iNOS activity
(Sham: 3.13 + 0.4; group B 18.73 + 2.6 vs group C: 7.34+ 1.8, p c 0.05).
Average myocardial AG-level was 15.4+ 2.6 @gtissue. Infarct aize (as per-
centage of risk area) was significantly smaller in AG treated snimals (group
B: 62.3+ 7.3%, C: 44.2 + 6.9%, p < 0.05). No hemodynamic difference be-
tween groups were noted prior to l/R but animals in group B and C developed
left ventricular dysfunction after I/R. In group C, however, LVSP and +dP/dt
were significantly higher after 48 h of l/R when compared to Group B (LVSP:
63.7 & 2.3 VS 51.1 + 5.2, p < 0.05; +dP/dt: 1852 + 624 VS 2691 + 629, p <
0,05). LVEDPwas significantly lowerin AG treated animals (3.58 zkO.8vs5.4
+ 0.7, p < 0.05). The present study provides further evidence that increased
iNOS activity contributes to myocsrdial dysfunction after I/R. Aminoguani-
dine, continuously administered, reduces infarct size and protects the hearl
against l/R induced injury.
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(l,4,5)-trisphoaphate mediates infarct size reduction
with preconditioning in isolated rabbit heart
B. Bauer, B.Z. Simkhovich, R.A. Kloner, K. Przyklenk. Heart /nst/tute, Good
Samaritan Hospita/ & USC, Los Angeles, CA, USA
The cellular mechanisms by which brief antecedent ischemia “preconditions”
(PC) the heart and limits infarct size cauaed by a subsequent sustained
period of corona~ artery occlusion (CO) remain unidentified. We propoae
that activation of the second messenger inositol (1,4,5)-trisphosphate (IP3:
a crucial mediator of calcium release from intracellular stores) during the PC
stimulus may play a focal role. To test this theory, 22 isolated Lsngendorff-
perfused rabbit hearts were subjected to 30 min of sustained CO and 2 h of
reperfusion. In Protoool 1, heatts received 2 5-rein episodes of regional PC
ischemia separated by 5 min of reflow (n =5) or a comparable control period
(n = 5) before sustained CO. Protocol 2 was identical, except neomycin
(0.16 mM: a potent and specific inhibitor of IP3 formation) was infused
